• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Search continues for a CMV vaccine for transplant recipients.针对移植受者的巨细胞病毒疫苗的研究仍在继续。
Lancet Haematol. 2016 Feb;3(2):e58-9. doi: 10.1016/S2352-3026(15)00286-0. Epub 2015 Dec 24.
2
Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.实体器官移植受者中更昔洛韦耐药巨细胞病毒感染的危险因素和结局。
Clin Infect Dis. 2017 Jul 1;65(1):57-63. doi: 10.1093/cid/cix259.
3
Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients: A Prospective Pharmacokinetic Study.缬更昔洛韦用于小儿实体器官移植受者巨细胞病毒预防的剂量：一项前瞻性药代动力学研究。
Pediatr Infect Dis J. 2017 Aug;36(8):745-750. doi: 10.1097/INF.0000000000001595.
4
Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay.巨细胞病毒（CMV）血清反应阳性的肾移植受者中，接受和未接受更昔洛韦治疗的CMV病毒血症的临床病程。CMV pp65抗原血症检测的纵向随访。
Am J Nephrol. 1998;18(5):373-8. doi: 10.1159/000013379.
5
Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature.肝移植术后巨细胞病毒感染的研究进展
Pharmacotherapy. 2017 Oct;37(10):1258-1271. doi: 10.1002/phar.1987. Epub 2017 Sep 3.
6
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial.从口服缬更昔洛韦与更昔洛韦静脉治疗实体器官移植受者巨细胞病毒病的随机研究中吸取的经验教训：VICTOR 试验。
Clin Infect Dis. 2016 May 1;62(9):1154-60. doi: 10.1093/cid/ciw084. Epub 2016 Feb 16.
7
Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.实体器官移植受者中耐更昔洛韦的巨细胞病毒感染：一项单中心回顾性队列研究。
Transpl Infect Dis. 2016 Jun;18(3):390-5. doi: 10.1111/tid.12537. Epub 2016 Jun 9.
8
Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.针对来自巨细胞病毒血清学阳性供体肝脏移植受者的口服更昔洛韦靶向预防的影响。
Transpl Infect Dis. 2005 Jun;7(2):57-62. doi: 10.1111/j.1399-3062.2005.00093.x.
9
Expanding role of cytomegalovirus as a human pathogen.巨细胞病毒作为人类病原体作用的扩展。
J Med Virol. 2016 Jul;88(7):1103-12. doi: 10.1002/jmv.24450. Epub 2016 Jan 5.
10
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.肺移植受者中耐更昔洛韦巨细胞病毒感染的单中心经验：治疗与转归
J Heart Lung Transplant. 2007 Dec;26(12):1286-92. doi: 10.1016/j.healun.2007.09.012. Epub 2007 Nov 19.

引用本文的文献

1
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.移植中巨细胞病毒感染的预防、诊断和管理的进展和挑战。
Clin Microbiol Rev. 2020 Oct 28;34(1). doi: 10.1128/CMR.00043-19. Print 2020 Dec 16.
2
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.使用淋巴细胞性脉络丛脑膜炎病毒载体联合糖蛋白B/pp65疫苗接种对先天性巨细胞病毒的附加保护作用。
Clin Vaccine Immunol. 2017 Jan 5;24(1). doi: 10.1128/CVI.00300-16. Print 2017 Jan.

本文引用的文献

1
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial.在异基因造血干细胞移植中补充PF03512676的巨细胞病毒嵌合表位疫苗（CMVPepVax）的病毒血症、免疫原性及生存结局：随机1b期试验
Lancet Haematol. 2016 Feb;3(2):e87-98. doi: 10.1016/S2352-3026(15)00246-X. Epub 2015 Dec 24.
2
Immune correlates of vaccine protection against HIV-1 acquisition.疫苗预防HIV-1感染的免疫相关因素。
Sci Transl Med. 2015 Oct 21;7(310):310rv7. doi: 10.1126/scitranslmed.aac7732.
3
The history of vaccination against cytomegalovirus.抗巨细胞病毒疫苗接种史。
Med Microbiol Immunol. 2015 Jun;204(3):247-54. doi: 10.1007/s00430-015-0388-z. Epub 2015 Mar 20.
4
Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies.巨细胞病毒的最新进展：药理和细胞疗法的最新情况
Biol Blood Marrow Transplant. 2015 Jan;21(1):24-9. doi: 10.1016/j.bbmt.2014.11.002. Epub 2014 Nov 11.
5
The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation.巨细胞病毒血清学状态对造血干细胞移植结局的作用。
Curr Opin Hematol. 2014 Nov;21(6):466-9. doi: 10.1097/MOH.0000000000000085.
6
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.五聚体复合物的病毒糖蛋白 H 是主要的目标，为强大的中和作用，由人类巨细胞病毒疫苗。
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4997-5005. doi: 10.1073/pnas.1316517110. Epub 2013 Dec 2.
7
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.HIV-1 疫苗功效试验的免疫相关性分析。
N Engl J Med. 2012 Apr 5;366(14):1275-86. doi: 10.1056/NEJMoa1113425.
8
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.新型治疗性巨细胞病毒 DNA 疫苗在异基因造血干细胞移植中的应用：一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Infect Dis. 2012 Apr;12(4):290-9. doi: 10.1016/S1473-3099(11)70344-9. Epub 2012 Jan 10.
9
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.用 MF59 佐剂的巨细胞病毒糖蛋白 B 疫苗在移植受者中的效果：一项 2 期随机安慰剂对照试验。
Lancet. 2011 Apr 9;377(9773):1256-63. doi: 10.1016/S0140-6736(11)60136-0.
10
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.造血细胞移植受者感染并发症预防指南：全球视角
Biol Blood Marrow Transplant. 2009 Oct;15(10):1143-238. doi: 10.1016/j.bbmt.2009.06.019.

Search continues for a CMV vaccine for transplant recipients.

作者信息

Boeckh Michael, Gilbert Peter B

机构信息

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; University of Washington, Seattle, WA, USA.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; University of Washington, Seattle, WA, USA.

出版信息

Lancet Haematol. 2016 Feb;3(2):e58-9. doi: 10.1016/S2352-3026(15)00286-0. Epub 2015 Dec 24.

DOI:10.1016/S2352-3026(15)00286-0
PMID:26853642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6294316/
Abstract
摘要